Skip to main content

Table 4 Optic nerve-based measures in treatment group

From: The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

 

Clinically Affected

(mean, SD)

Clinically Unaffected

(mean, SD)

p

Number of optic nerves (n)

14

6

 

LogMAR

0.15 (0.20)

0.15 (0.17)

0.9640

Sloan 25%

0.31 (0.26)

0.30 (0.20)

0.9746

Sloan 5%

0.66 (0.35)

0.53 (0.18)

0.4282

Sloan 1.25%

1.0 (0.46)

0.75 (0.15)

0.1544

FM-100 Square-Root Total Error Score

16.0 (4.4)

13.5 (2.8)

0.2188

Visual field Mean Deviance

-4.28 (2.04)

-3.04 (2.06)

0.2267

RNFL average thickness (microns)

72.4 (12.9)

85.5 (10.2)

0.0399

Macular volume (mm 3 )

6.1 (0.5)

6.6 (0.3)

0.0624

Full field VER latency (milliseconds)

136.3 (15.2)

114.8 (7.1)

0.0045

Full-field VER amplitude (microvolts)

4.8 (1.9)

4.5 (2.3)

0.7669

Optic nerve area (mm 2 )

8.1 (1.3)

8.9 (1.1)

0.1961

Optic nerve MTR (pu)

28.4 (2.9)

31.3 (2.3)

0.0515

Optic nerve DTI Mean Diffusivity (×10 -3 mm 2 /s)

1.17 (0.29)

1.25 (0.26)

0.5415

Optic nerve DTI Fractional Anisotropy (×10 3 )

298.2 (91.2)

353.3 (88.6)

0.2282

Optic nerve DTI Radial Diffusivity (×10 -3 mm 2 /s)

0.99 (0.26)

1.03 (0.24)

0.7004

Optic nerve DTI Axial Diffusivity (×10 -3 mm 2 /s)

1.53 (0.42)

1.70 (0.35)

0.4012

  1. FM-100 = Farnsworth-Munsell 100-Hue test; RNFL = Retinal Nerve Fibre Layer; VER = Visual Evoked Response; DTI = Diffusion Tensor Imaging.